CD8A and neoplasm: Against this backdrop, nanodrugs promote the release of tumor antigens and DAMPs, allowing antigen-presenting cells to capture and present them to CD8+ T cells, leading to the activation of CD8+ T cells and enhancing their specific cytotoxic effects against cancer cells.